August 29, 2024mBioOpen Access

Discovery of GuaB inhibitors with efficacy against Acinetobacter baumannii infection

View Full Paper

Ask AI

Bookmark

Authors

EKEric M. KofoedOregon Health & Science University IAIgnacio Aliagas TCTerry D. CrawfordGenesys (United States)

Discussion

Member takes

Implication

Preclinical evaluation demonstrates efficacy of GuaB inhibitors against Acinetobacter baumannii infection, highlighting a targeted pathway for novel antibiotic development.

Key Points

Inhibition of GuaB blocks essential guanine nucleotides and demonstrates antibacterial efficacy against drug-resistant Acinetobacter baumannii infection.
Targeting of the rate-limiting biosynthetic step utilizes mycophenolic acid derivatives to disrupt cellular translation and signal transduction systems.
Discovery of selective GuaB inhibitors highlights a viable antimicrobial mechanism against Acinetobacter baumannii, though clinical evaluation remains needed.

Cite This Study

Kofoed et al. (2024) studied this question.

synapsesocial.com/papers/68e5a5efb6db64358753ff86 https://doi.org/10.1128/mbio.00897-24

View Full Paper

Ask AI

Bookmark

Implication

Preclinical evaluation demonstrates efficacy of GuaB inhibitors against Acinetobacter baumannii infection, highlighting a targeted pathway for novel antibiotic development.

Discovery of GuaB inhibitors with efficacy against Acinetobacter baumannii infection

Discussion

Member takes

Implication

Key Points

Cite This Study

Discovery of GuaB inhibitors with efficacy against Acinetobacter baumannii infection

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider